MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated Operating Income 2011-2026 | ARAY
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.84 M | 504 K | 2.38 M | 8.15 M | 22.2 M | 12.5 M | 583 K | -3.8 M | -9.82 M | -4.87 M | -19.2 M | -18.1 M | -80.7 M | -56.2 M | -27.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.2 M | -80.7 M | -11.1 M |
Quarterly Operating Income Accuray Incorporated
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.6 M | -11.3 M | - | 1.05 M | 4.71 M | -2.15 M | - | -4.56 M | -3.96 M | 2.21 M | - | 2.32 M | 2.7 M | -2.18 M | 523 K | -292 K | 3.98 M | 2.41 M | 6.39 M | 4.43 M | 8.2 M | 5.47 M | 8.2 M | 5.47 M | 3.62 M | -4.28 M | 3.62 M | -4.28 M | -868 K | -4.69 M | -868 K | -4.69 M | -1.02 M | -2.05 M | -1.02 M | -2.05 M | -4.82 M | -6.55 M | -4.82 M | -6.55 M | -124 K | -7.23 M | -124 K | -7.23 M | -3.59 M | -15.3 M | -3.59 M | -15.3 M | -716 K | -12.3 M | -716 K | -12.3 M | -22.3 M | -20.6 M | -22.3 M | -34.9 M | -5.45 M | -24.7 M | -7.31 M | -24.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.2 M | -34.9 M | -4.56 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.19 | 3.79 % | $ 3.42 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 10.66 | 2.3 % | $ 1.44 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.08 | 4.09 % | $ 864 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 12.79 | 1.51 % | $ 1.92 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 8.36 | -0.24 % | $ 600 M |  Israel |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 71.81 | 2.94 % | $ 106 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.75 | -1.76 % | $ 1.14 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.69 | 6.83 % | $ 37.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.12 | 3.91 % | $ 154 M |  France |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-39 M | $ 64.8 | 2.08 % | $ 1.92 B |  Costa-rica |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 11.12 | 0.82 % | $ 301 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.43 | 0.08 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.22 | 1.37 % | $ 1.35 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 13.58 | 1.08 % | $ 878 M | Israel |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.31 | -1.5 % | $ 21.1 M | USA |
 |
Abbott Laboratories
ABT
|
8.05 B | $ 111.67 | 1.56 % | $ 194 B | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.84 | 0.31 % | $ 352 M | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 268.33 | 2.72 % | $ 7.57 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.19 | 2.0 % | $ 708 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 62.26 | 1.34 % | $ 3.4 B |  Britain |
 |
AxoGen
AXGN
|
-7.85 M | $ 32.83 | -0.03 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
608 M | $ 176.49 | 4.15 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 33.53 | 2.35 % | $ 5 K | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-6.45 M | $ 3.77 | 2.72 % | $ 155 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 17.17 | 0.35 % | $ 403 M | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 86.71 | 3.14 % | $ 3.01 B | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 4.46 | 1.02 % | $ 659 M | USA |